21 – 29 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2018
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Caffeine and incidence of dyspnea in patients treated with ticagrelor
(
- Contribution to journal › Letter
-
Mark
Bivalirudin versus heparin with primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
- 2016
-
Mark
Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis : A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Hypertension in adults with repaired coarctation of the aorta
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction - A registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
(
- Contribution to journal › Article
-
Mark
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment : A nationwide Swedish registry report
(
- Contribution to journal › Article
- 2014
-
Mark
Circulating fibrosis biomarkers and risk of atrial fibrillation : The Cardiovascular Health Study (CHS)
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »